BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31372045)

  • 1. Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells.
    He H; Qie S; Guo Q; Chen S; Zou C; Lu T; Su Y; Zong J; Xu H; He D; Xu Y; Chen B; Pan J; Sang N; Lin S
    Cancer Manag Res; 2019; 11():6411-6424. PubMed ID: 31372045
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas.
    Lin S; Guo Q; Wen J; Li C; Lin J; Cui X; Sang N; Pan J
    J Exp Clin Cancer Res; 2014 Mar; 33(1):26. PubMed ID: 24606961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2/FAK/SOX6 signaling pathway in nasopharyngeal carcinoma.
    Li J; Zhang Z; Feng X; Shen Z; Sun J; Zhang X; Bu F; Xu M; Tan C; Wang Z
    Cell Biol Toxicol; 2022 Apr; 38(2):259-272. PubMed ID: 33797657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
    Qie S; Sang N
    J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable knockdown of ZBTB7A promotes cell proliferation and progression in nasopharyngeal carcinoma.
    Liu F; Tang F; Lan J; Jiao W; Si Y; Lu W; Mo M; Li B; Lu J; Wei J; Qin Y; Xiao R; Zhang B; Wang Y; Xiong W
    Tumori; 2018; 104(1):37-42. PubMed ID: 29699474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
    Lin C; Sun L; Huang S; Weng X; Wu Z
    Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
    Na SS; Aldonza MB; Sung HJ; Kim YI; Son YS; Cho S; Cho JY
    Biochim Biophys Acta; 2015 Jun; 1854(6):668-76. PubMed ID: 25463045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting stanniocalcin 2 reduces sunitinib resistance of Caki-1 renal cancer cells under hypoxia condition.
    Chu H; Xie W; Guo C; Shi H; Gu J; Qin Z; Xie Y
    Ann Med Surg (Lond); 2023 Dec; 85(12):5963-5971. PubMed ID: 38098599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
    Law AY; Wong CK
    Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
    Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
    Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma.
    Zhang ZH; Wu YG; Qin CK; Rong ZH; Su ZX; Xian GZ
    Oncol Lett; 2014 Nov; 8(5):2160-2164. PubMed ID: 25289096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Stanniocalcin 2 (STC2) Expression Promotes Post-Radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells [Corrigendum].
    Cancer Manag Res; 2019; 11():10409. PubMed ID: 31853197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.
    Hou J; Wang Z; Xu H; Yang L; Yu X; Yang Z; Deng Y; Meng J; Feng Y; Guo X; Yang G
    PLoS One; 2015; 10(4):e0122179. PubMed ID: 25830567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
    Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
    World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
    Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
    Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma.
    Wu M; Ye X; Deng X; Wu Y; Li X; Zhang L
    Onco Targets Ther; 2016; 9():1647-56. PubMed ID: 27051300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
    Law AY; Wong CK
    Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.